SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-18-000054
Filing Date
2018-03-16
Accepted
2018-03-16 20:35:42
Documents
1
Period of Report
2018-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_152124692840531.html 4  
1 FORM 4 wf-form4_152124692840531.xml 4 10422
  Complete submission text file 0001479290-18-000054.txt   11726
Mailing Address 618 MIRADA AVENUE STANFORD CA 94305
Business Address
GARDNER PHYLLIS (Reporting) CIK: 0001238646 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 18697249

Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations